As Sales Slip, Merck & Co. Plans 7,200 Job Cuts
This article was originally published in The Pink Sheet Daily
Executive Summary
Facing lower sales of Vytorin, Singulair and Gardasil, on top of recent pipeline disappointments, Merck implements a new restructuring initiative.
You may also be interested in...
Sanofi Pasteur To File Quick Response To cGMP Violations At French Plant
An FDA untitled letter cites switch in pyrogen testing reagent and failure to thoroughly investigate problems and acknowledges Sanofi's commitment to corrections.
Sanofi Pasteur To File Quick Response To cGMP Violations At French Plant
An FDA untitled letter cites switch in pyrogen testing reagent and failure to thoroughly investigate problems and acknowledges Sanofi's commitment to corrections.
Merck U.S. Restructuring Not To Blame For Q1 Sales Drop, Execs Say
Merck is assuring analysts that its massive commercial restructuring continues to benefit, not stifle, product growth, as company executives reported lower-than-expected sales and earnings April 21